inactivated virus vaccine coronavac (Sinovac BioTech)
90
Structured Review
Sinovac BioTech
inactivated virus vaccine coronavac
Inactivated Virus Vaccine Coronavac, supplied by Sinovac BioTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inactivated+virus+vaccines+coronavac/inactivated+vaccine+coronavac/pmc12255310-56-9-13
Average 90 stars, based on 1 article reviews
Inactivated Virus Vaccine Coronavac, supplied by Sinovac BioTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inactivated+virus+vaccines+coronavac/inactivated+vaccine+coronavac/pmc12255310-56-9-13
Average 90 stars, based on 1 article reviews
inactivated virus vaccine coronavac - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Vaccines:Article Title: Development of safe and highly protective live-attenuated SARS-CoV-2 vaccine candidates by genome recoding Article Snippet: .. Among the most widely administered vaccines are mRNA vaccines developed by Pfizer–BioNTech (BNT162b2, or Comirnaty) and Moderna (mRNA-1273), non-replicating adenovirus-vectored vaccines developed by the Gamaleya Research Institute (Sputnik V), University of Oxford–AstraZeneca (AZD1222, Vaxzevria or Covishield) and Janssen–Johnson & Johnson (Ad26.COV2.S), Article Title: Development of safe and highly protective live-attenuated SARS-CoV-2 vaccine candidates by genome recoding Article Snippet: .. Among themost widely administered vaccines aremRNA vaccines developed by Pfizer–BioNTech (BNT162b2, or Comirnaty) and Moderna (mRNA-1273), non-replicating adenovirusvectored vaccines developed by the Gamaleya Research Institute (Sputnik V), University of Oxford–AstraZeneca (AZD1222, Vaxzevria or Covishield) and Janssen–Johnson & Johnson (Ad26.COV2.S), Virus:Article Title: Development of safe and highly protective live-attenuated SARS-CoV-2 vaccine candidates by genome recoding Article Snippet: .. Among the most widely administered vaccines are mRNA vaccines developed by Pfizer–BioNTech (BNT162b2, or Comirnaty) and Moderna (mRNA-1273), non-replicating adenovirus-vectored vaccines developed by the Gamaleya Research Institute (Sputnik V), University of Oxford–AstraZeneca (AZD1222, Vaxzevria or Covishield) and Janssen–Johnson & Johnson (Ad26.COV2.S), Article Title: Development of safe and highly protective live-attenuated SARS-CoV-2 vaccine candidates by genome recoding Article Snippet: .. Among themost widely administered vaccines aremRNA vaccines developed by Pfizer–BioNTech (BNT162b2, or Comirnaty) and Moderna (mRNA-1273), non-replicating adenovirusvectored vaccines developed by the Gamaleya Research Institute (Sputnik V), University of Oxford–AstraZeneca (AZD1222, Vaxzevria or Covishield) and Janssen–Johnson & Johnson (Ad26.COV2.S), other:Article Title: Naive and Memory B Cell BCR Repertoires in Individuals Immunized with an Inactivated SARS-CoV-2 Vaccine. Article Snippet: Among these are |